Drug Profile
Estradiol vaginal - AbbVie
Alternative Names: WC 3011Latest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Warner Chilcott
- Developer Allergan; Warner Chilcott
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atrophic vaginitis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 24 Dec 2019 Discontinued - Phase-II for Atrophic vaginitis in USA (Vaginal, Gel) (Allergan website, December 2019)
- 24 Dec 2019 Discontinued - Phase-III for Atrophic vaginitis in USA (Vaginal, Capsule) (Allergan website, December 2019)